Your browser doesn't support javascript.
loading
Afatinib vs erlotinib for second-line treatment of Chinese patients with advanced squamous cell carcinoma of the lung.
Lu, Shun; Li, Wei; Zhou, Caicun; Hu, Cheng-Ping; Qin, Shukui; Cheng, Gang; Feng, Jifeng; Wang, Jie; Cseh, Agnieszka; Peil, Barbara; Gibson, Neil; Ehrnrooth, Eva; Zhang, Li.
Afiliação
  • Lu S; Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China, shun_lu@hotmail.com.
  • Li W; Cancer Center, First Hospital of Jilin University, Changchun, China.
  • Zhou C; Department of Oncology, Shanghai Pulmonary Hospital, Shanghai, China.
  • Hu CP; Department of Respiratory Medicine, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Qin S; People's Liberation Army Cancer Center, Nanjing Bayi Hospital, Nanjing, Jiangsu, China.
  • Cheng G; Department of Medical Oncology, Beijing Hospital, National Center of Gerontology, Beijing, China.
  • Feng J; Department of Internal Medicine, Jiangsu Provincial Tumor Hospital, Nanjing, China.
  • Wang J; Department of Internal Medicine, Capital Medical University, Beijing, China.
  • Cseh A; Peking University School of Oncology, Beijing Cancer Hospital, Beijing, China.
  • Peil B; Department of Medical Affairs, Boehringer Ingelheim RCV GmbH & Co. KG, Vienna, Austria.
  • Gibson N; Biostatistics, Boehringer Ingelheim Pharma GmbH & Co. KG. Ingelheim, Germany.
  • Ehrnrooth E; Translational Medicine and Clinical Oncology, Boehringer Ingelheim Pharma GmbH & Co. KG. Biberach, Germany.
  • Zhang L; Division of Oncology, Boehringer Ingelheim, Danmark A/S, Copenhagen, Denmark.
Onco Targets Ther ; 11: 8565-8573, 2018.
Article em En | MEDLINE | ID: mdl-30573970

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Onco Targets Ther Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Onco Targets Ther Ano de publicação: 2018 Tipo de documento: Article